Regulus Therapeutics Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Regulus Therapeutics Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2011 to Q3 2024.
  • Regulus Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 65.5M shares, a 224% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 65.5M +45.3M +224% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 65.5M +46M +236% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 65.5M +48.6M +288% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 20.2M +3.38M +20.1% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 20.2M +3.38M +20.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 19.5M +4.85M +33.1% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 16.9M -129M -88.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 16.8M +2.24M +15.4% Dec 31, 2022 10-K 2024-03-21
Q3 2022 16.8M -70.2M -80.7% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 14.6M -72.4M -83.2% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 146M +71.3M +95.5% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 14.6M -52.8M -78.4% Dec 31, 2021 10-K 2023-03-23
Q3 2021 87M +47.9M +122% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 87M +51.1M +142% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 74.7M +47.1M +171% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 67.4M +46.4M +221% Dec 31, 2020 10-K 2022-03-11
Q3 2020 39.2M +18.2M +87.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 35.9M +15.1M +72.5% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 27.6M +16.8M +155% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 21M +12.2M +138% Dec 31, 2019 10-K 2021-03-09
Q3 2019 20.9M +12.2M +139% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 20.8M -83.6M -80.1% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 10.8M -93.5M -89.6% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 8.82M +156K +1.8% Dec 31, 2018 10-K 2020-03-12
Q3 2018 8.75M -95.2M -91.6% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 104M +51.2M +96.4% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 104M +51.1M +96.2% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 8.66M -44.3M -83.6% Dec 31, 2017 10-K 2019-03-18
Q3 2017 104M +51M +96.4% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 53.2M +395K +0.75% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 53.2M +408K +0.77% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 52.9M +256K +0.49% Dec 31, 2016 10-K 2018-03-08
Q3 2016 52.9M +581K +1.11% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 52.8M +1.25M +2.43% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 52.8M +2.01M +3.96% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 52.7M +3.72M +7.61% Dec 31, 2015 10-K 2017-03-03
Q3 2015 52.3M +8.9M +20.5% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 51.5M +8.15M +18.8% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 50.8M +7.42M +17.1% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 48.9M +7.16M +17.1% Dec 31, 2014 10-K 2016-02-23
Q3 2014 43.4M +1.67M +3.99% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 43.4M +7.3M +20.2% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 43.3M +7.38M +20.5% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 41.8M +5.96M +16.6% Dec 31, 2013 10-K 2015-02-19
Q3 2013 41.8M +41.6M +27171% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 36.1M Jun 30, 2013 10-Q/A 2013-08-16
Q1 2013 36M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 35.8M +35.7M +23291% Dec 31, 2012 10-K 2014-02-28
Q3 2012 153K Sep 30, 2012 10-Q 2012-11-19
Q4 2011 153K Dec 31, 2011 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.